Osthole Improves Cognitive Function of Vascular Dementia Rats: Reducing Aβ Deposition via Inhibition NLRP3 Inflammasome

Biol Pharm Bull. 2020;43(9):1315-1323. doi: 10.1248/bpb.b20-00112.

Abstract

Vascular dementia (VD) is a common neurodegenerative disease, and the cognitive dysfunction is a major manifestation of VD. Lots of evidences showed that beta-amyloid (Aβ) deposition and neuroinflammation act as vital elements in the progress of VD. The previous studies showed that osthole (OST) can improve the cognitive function of VD and Alzheimer's disease (AD). However, the effect of OST on Aβ in VD brain is still unclear. Chronic cerebral hypoperfusion (CCH) of rats were used to investigate the effect of OST on Aβ through nod-like receptor protein 3 (NLRP3) inflammasome in this study. Morris Water Maze and Y-maze were used to test the spatial learning, memory and working abilities. Hematoxylin-eosin (H&E) and Nissl staining were used to observe the morphology and number of hippocampal neurons. Immunofluorescence staining was used to observe the number of microglia activated. Western blot was used to detect the expression of proteins. The study results showed that OST obviously enhanced the spatial learning, memory and working abilities induced by modified bilateral common carotid artery occlusion (BCCAO) in rats, improved the pathological damage of hippocampal neurons induced by BCCAO in rats, inhibited the activation of microglia induced by BCCAO in rats. Furthermore, this study also discovered that OST reduced Aβ deposition in VD hippocampus via inhibition the NLRP3 inflammasome. Together, these results suggest that OST reduces Aβ deposition via inhibition NLRP3 inflammasome in microglial in VD.

Keywords: beta-amyloid; chronic cerebral hypoperfusion; inflammasome; osthole; vascular dementia.

MeSH terms

  • Administration, Oral
  • Amyloid beta-Peptides / antagonists & inhibitors*
  • Amyloid beta-Peptides / metabolism
  • Animals
  • Behavior Observation Techniques
  • Behavior, Animal / drug effects
  • Brain / drug effects
  • Brain / immunology
  • Brain / pathology
  • Cognitive Dysfunction / drug therapy*
  • Cognitive Dysfunction / immunology
  • Cognitive Dysfunction / pathology
  • Coumarins / administration & dosage*
  • Dementia, Vascular / complications
  • Dementia, Vascular / diagnosis
  • Dementia, Vascular / drug therapy*
  • Dementia, Vascular / immunology
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Humans
  • Inflammasomes / antagonists & inhibitors*
  • Inflammasomes / immunology
  • Inflammasomes / metabolism
  • Male
  • NLR Family, Pyrin Domain-Containing 3 Protein / antagonists & inhibitors
  • NLR Family, Pyrin Domain-Containing 3 Protein / metabolism
  • Rats

Substances

  • Amyloid beta-Peptides
  • Coumarins
  • Inflammasomes
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Nlrp3 protein, rat
  • osthol